Now showing items 1-9 of 9

    • Adorno Farías, Daniela; Ortega Pinto, Ana; Gajardo, Paulina; Salazar, Ana; Morales Bozo, Irene; Werlinger, Fabiola; Rojas-Flores, Sandra; Molina Berríos, Alfredo Enrique; Echeverría-López, Sonia; Jara Sandoval, José; Jara, Lilian; Urzúa Orellana, Blanca (Bauru School of Dentistry, University of Sao Paulo, 2019)
      Amelogenesis imperfecta (AI) is a group of enamel development disorders that alter the structure and chemical composition of the tissue. There is great variability in the clinical presentation; according to Witkop, AI can ...
    • Morales, Sebastián; De Mayo, Tomas; Gulppi, Felipe Andrés; González Hormazábal, Patricio; Carrasco, Valentina; Reyes, José Miguel; Gómez, Fernando; Waugh, Enrique; Jara, Lilian (MDPI AG, 2018)
      © 2018 by the authors. Licensee MDPI, Basel, Switzerland. Breast cancer (BC) is one of the most frequent tumors affecting women worldwide. microRNAs (miRNAs) single-nucleotide polymorphisms (SNPs) likely contribute to BC ...
    • González Hormazábal, Patricio; Romero, Sandra; Musleh, Maher; Bustamante, Marco; Stambuk, Juan; Pisano, Raul; Lanzarini, Enrique; Chiong, Hector; Rojas, Jorge; Castro, Victor Gonzalo; Jara, Lilian; Berger, Zoltan (International Institute of Anticancer Research, 2018)
      © 2018 International Institute of Anticancer Research. All rights reserved. Background/Aim: Inflammation is a key process in gastric carcinogenesis. Cytokines are mediators of inflammation and are involved in metastasis ...
    • Román, Juan José Mora; Del Campo, Miguel; Villar, Javiera; Paolini, Francesca; Curzio, Gianfranca; Venuti, Aldo; Jara, Lilian; Ferreira, Jorge; Murgas, Paola; Lladser, Alvaro; Manubens, Augusto; Becker, María Inés (Hindawi Limited, 2019)
      Mollusk hemocyanins have been used for decades in immunological and clinical applications as natural, nontoxic, nonpathogenic, and nonspecific immunostimulants for the treatment of superficial bladder cancer, as ...
    • Urzúa Orellana, Blanca; Martínez, Blanca; Ortega Pinto, Ana; Adorno Farías, Daniela; Morales Bozo, Irene; Riadi, Gonzalo; Jara, Lilian; Plaza, Anita; Lefimil, Claudia; Lozano, Carla; Reyes, Monserrat (Elsevier, 2015)
      Objective: Amelogenesis imperfecta (AI) is a group of clinically and genetically heterogeneous inherited conditions, causing alterations in the structure of enamel and chemical composition of enamel matrix during development. ...
    • González Hormazábal, Patricio; Musleh, Maher; Bustamante, Marco; Stambuk, Juan; Pisano, Raul; Valladares, Hector; Lanzarini, Enrique; Chiong, Hector; Rojas, Jorge; Suazo, Jose; Gonzalo Castro, V.; Jara, Lilian; Berger, Zoltan (MDPI AG, 2019)
      The RAS/RAF/MEK/ERK pathway regulates certain cellular functions, including cell proliferation, differentiation, survival, and apoptosis. Dysregulation of this pathway leads to the occurrence and progression of cancers ...
    • González Hormazábal, Patricio; Reyes, Jose M.; Blanco, Rafael; Bravo, Teresa; Carrera, Ignacio; Peralta, Octavio; Gomez, Fernando; Waugh, Enrique; Margarit, Sonia; Ibañez, Gladys; Santos, José Luis; Jara, Lilian (2012)
      Since the discovery of the BRCA1 and BRCA2 genes, much work has been carried out to identify further breast cancer (BC) susceptibility genes. BARD1 (BRCA1-associated ring domain) was originally identified as a BRCA1-interacting ...
    • Woudt, Lisanne; Di Capua, Gabriella A.; Krahn, Martin; Castiglioni, Claudia; Hughes García, Ricardo; Campero Soffia, Mario; Trangulao, Alejandra; González Hormazabal, Patricio; Godoy Herrera, Raúl; Levy, Nicolas; Urtizberea, Jon Andoni; Jara, Lilian; Bevilacqua, Jorge (WILEY-BLACKWELL, 2016)
      Introduction: Understanding the natural history of dysferlinopathy is essential to design and quantify novel therapeutic protocols. Our aim in this study was to assess, clinically and functionally, a cohort of patients ...
    • Cerceño Osorio, Kerube Noemi (Universidad de Chile, 2012)
      El cáncer de mama (CM) constituye uno de los mayores problemas para la salud de la mujer actual. Los factores de riesgo atribuibles al desarrollo de la enfermedad incluyen: edad, et nia, exposición hormonal y factores ...